Edward White
Stock Analyst at HC Wainwright & Co.
(1.85)
# 3,297
Out of 5,045 analysts
358
Total ratings
30.49%
Success rate
-8.03%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $7.56 | +336.51% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $9.13 | +86.20% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $5.03 | +198.21% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.00 | +100.00% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.49 | +973.83% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.46 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $9.46 | +746.09% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.38 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $3.94 | +407.61% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.80 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $4.04 | +296.04% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.08 | +311.18% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.32 | +506.06% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $18.04 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.78 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $34.02 | +61.67% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $13.39 | +280.88% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $5.46 | +28.21% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $5.96 | +839.60% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $10.40 | +198.08% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.94 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $9.30 | +7,426.88% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $31.60 | -5.06% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.29 | +830.23% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.56
Upside: +336.51%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $9.13
Upside: +86.20%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $5.03
Upside: +198.21%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.00
Upside: +100.00%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.49
Upside: +973.83%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.46
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $9.46
Upside: +746.09%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.38
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $3.94
Upside: +407.61%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.80
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $4.04
Upside: +296.04%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.08
Upside: +311.18%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.32
Upside: +506.06%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $18.04
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.78
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $34.02
Upside: +61.67%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $13.39
Upside: +280.88%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $5.46
Upside: +28.21%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $5.96
Upside: +839.60%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $10.40
Upside: +198.08%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.94
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $9.30
Upside: +7,426.88%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $31.60
Upside: -5.06%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.29
Upside: +830.23%